Global Asthma Therapeutics Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI02241141

Publication Date:

February 14, 2024

Pages:

131

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Asthma Therapeutics market size was valued at US$ 21590 million in 2023. With growing demand in downstream market, the Asthma Therapeutics is forecast to a readjusted size of US$ 27320 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Asthma Therapeutics market. Asthma Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Asthma Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Asthma Therapeutics market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Asthma Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Asthma Therapeutics market. It may include historical data, market segmentation by Type (e.g., Inhalation, Parenteral), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Asthma Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Asthma Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Asthma Therapeutics industry. This include advancements in Asthma Therapeutics technology, Asthma Therapeutics new entrants, Asthma Therapeutics new investment, and other innovations that are shaping the future of Asthma Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Asthma Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Asthma Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Asthma Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Asthma Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Asthma Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Asthma Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Asthma Therapeutics market.
Market Segmentation:
Asthma Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Inhalation
Parenteral
Oral
Segmentation by application
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
Boehringer Ingelheim
F. Hoffmann-La Roche
GSK
Merck
Horizon Pharma
Mitsubishi Tanabe Pharma
Sanofi
Mundipharma
Nycomed
Kissei Pharmaceutical
ALK-Abello
Array BioPharma
SAMA Pharmaceuticals
Whanin Pharmaceutical

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Asthma Therapeutics Market Size 2019-2030
2.1.2 Asthma Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Asthma Therapeutics Segment by Type
2.2.1 Inhalation
2.2.2 Parenteral
2.2.3 Oral
2.3 Asthma Therapeutics Market Size by Type
2.3.1 Asthma Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Asthma Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Asthma Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Asthma Therapeutics Market Size by Application
2.5.1 Asthma Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Asthma Therapeutics Market Size Market Share by Application (2019-2024)
3 Asthma Therapeutics Market Size by Player
3.1 Asthma Therapeutics Market Size Market Share by Players
3.1.1 Global Asthma Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Asthma Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Asthma Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Asthma Therapeutics by Regions
4.1 Asthma Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Asthma Therapeutics Market Size Growth (2019-2024)
4.3 APAC Asthma Therapeutics Market Size Growth (2019-2024)
4.4 Europe Asthma Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Asthma Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Asthma Therapeutics Market Size by Country (2019-2024)
5.2 Americas Asthma Therapeutics Market Size by Type (2019-2024)
5.3 Americas Asthma Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Asthma Therapeutics Market Size by Region (2019-2024)
6.2 APAC Asthma Therapeutics Market Size by Type (2019-2024)
6.3 APAC Asthma Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Asthma Therapeutics by Country (2019-2024)
7.2 Europe Asthma Therapeutics Market Size by Type (2019-2024)
7.3 Europe Asthma Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Asthma Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Asthma Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Asthma Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Asthma Therapeutics Market Forecast
10.1 Global Asthma Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Asthma Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Asthma Therapeutics Forecast
10.1.3 APAC Asthma Therapeutics Forecast
10.1.4 Europe Asthma Therapeutics Forecast
10.1.5 Middle East & Africa Asthma Therapeutics Forecast
10.2 Americas Asthma Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Asthma Therapeutics Market Forecast
10.2.2 Canada Asthma Therapeutics Market Forecast
10.2.3 Mexico Asthma Therapeutics Market Forecast
10.2.4 Brazil Asthma Therapeutics Market Forecast
10.3 APAC Asthma Therapeutics Forecast by Region (2025-2030)
10.3.1 China Asthma Therapeutics Market Forecast
10.3.2 Japan Asthma Therapeutics Market Forecast
10.3.3 Korea Asthma Therapeutics Market Forecast
10.3.4 Southeast Asia Asthma Therapeutics Market Forecast
10.3.5 India Asthma Therapeutics Market Forecast
10.3.6 Australia Asthma Therapeutics Market Forecast
10.4 Europe Asthma Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Asthma Therapeutics Market Forecast
10.4.2 France Asthma Therapeutics Market Forecast
10.4.3 UK Asthma Therapeutics Market Forecast
10.4.4 Italy Asthma Therapeutics Market Forecast
10.4.5 Russia Asthma Therapeutics Market Forecast
10.5 Middle East & Africa Asthma Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Asthma Therapeutics Market Forecast
10.5.2 South Africa Asthma Therapeutics Market Forecast
10.5.3 Israel Asthma Therapeutics Market Forecast
10.5.4 Turkey Asthma Therapeutics Market Forecast
10.5.5 GCC Countries Asthma Therapeutics Market Forecast
10.6 Global Asthma Therapeutics Forecast by Type (2025-2030)
10.7 Global Asthma Therapeutics Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Asthma Therapeutics Product Offered
11.1.3 AstraZeneca Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Asthma Therapeutics Product Offered
11.2.3 Boehringer Ingelheim Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Boehringer Ingelheim Main Business Overview
11.2.5 Boehringer Ingelheim Latest Developments
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Information
11.3.2 F. Hoffmann-La Roche Asthma Therapeutics Product Offered
11.3.3 F. Hoffmann-La Roche Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 F. Hoffmann-La Roche Main Business Overview
11.3.5 F. Hoffmann-La Roche Latest Developments
11.4 GSK
11.4.1 GSK Company Information
11.4.2 GSK Asthma Therapeutics Product Offered
11.4.3 GSK Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 GSK Main Business Overview
11.4.5 GSK Latest Developments
11.5 Merck
11.5.1 Merck Company Information
11.5.2 Merck Asthma Therapeutics Product Offered
11.5.3 Merck Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Merck Main Business Overview
11.5.5 Merck Latest Developments
11.6 Horizon Pharma
11.6.1 Horizon Pharma Company Information
11.6.2 Horizon Pharma Asthma Therapeutics Product Offered
11.6.3 Horizon Pharma Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Horizon Pharma Main Business Overview
11.6.5 Horizon Pharma Latest Developments
11.7 Mitsubishi Tanabe Pharma
11.7.1 Mitsubishi Tanabe Pharma Company Information
11.7.2 Mitsubishi Tanabe Pharma Asthma Therapeutics Product Offered
11.7.3 Mitsubishi Tanabe Pharma Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Mitsubishi Tanabe Pharma Main Business Overview
11.7.5 Mitsubishi Tanabe Pharma Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Asthma Therapeutics Product Offered
11.8.3 Sanofi Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Mundipharma
11.9.1 Mundipharma Company Information
11.9.2 Mundipharma Asthma Therapeutics Product Offered
11.9.3 Mundipharma Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Mundipharma Main Business Overview
11.9.5 Mundipharma Latest Developments
11.10 Nycomed
11.10.1 Nycomed Company Information
11.10.2 Nycomed Asthma Therapeutics Product Offered
11.10.3 Nycomed Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Nycomed Main Business Overview
11.10.5 Nycomed Latest Developments
11.11 Kissei Pharmaceutical
11.11.1 Kissei Pharmaceutical Company Information
11.11.2 Kissei Pharmaceutical Asthma Therapeutics Product Offered
11.11.3 Kissei Pharmaceutical Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Kissei Pharmaceutical Main Business Overview
11.11.5 Kissei Pharmaceutical Latest Developments
11.12 ALK-Abello
11.12.1 ALK-Abello Company Information
11.12.2 ALK-Abello Asthma Therapeutics Product Offered
11.12.3 ALK-Abello Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 ALK-Abello Main Business Overview
11.12.5 ALK-Abello Latest Developments
11.13 Array BioPharma
11.13.1 Array BioPharma Company Information
11.13.2 Array BioPharma Asthma Therapeutics Product Offered
11.13.3 Array BioPharma Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Array BioPharma Main Business Overview
11.13.5 Array BioPharma Latest Developments
11.14 SAMA Pharmaceuticals
11.14.1 SAMA Pharmaceuticals Company Information
11.14.2 SAMA Pharmaceuticals Asthma Therapeutics Product Offered
11.14.3 SAMA Pharmaceuticals Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 SAMA Pharmaceuticals Main Business Overview
11.14.5 SAMA Pharmaceuticals Latest Developments
11.15 Whanin Pharmaceutical
11.15.1 Whanin Pharmaceutical Company Information
11.15.2 Whanin Pharmaceutical Asthma Therapeutics Product Offered
11.15.3 Whanin Pharmaceutical Asthma Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Whanin Pharmaceutical Main Business Overview
11.15.5 Whanin Pharmaceutical Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂